Modified Terminalia randii gum as a binder in metronidazole tablet formulation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
B<strong>in</strong>der<br />
Conc<br />
of<br />
b<strong>in</strong>de<br />
r<br />
Bulk density<br />
(g/ml)<br />
<strong>Modified</strong> term<strong>in</strong>alia <strong>randii</strong> <strong>gum</strong> <strong>as</strong> a <strong>b<strong>in</strong>der</strong> <strong>in</strong> <strong>metronidazole</strong> <strong>tablet</strong> <strong>formulation</strong><br />
Table 1: Micromeritic Properties of Granules<br />
Tapped<br />
density<br />
(g/ml)<br />
Flow rate<br />
(g/sec)<br />
Angle<br />
repose<br />
( O )<br />
of<br />
Carr’s<br />
<strong>in</strong>dex<br />
( O / O )<br />
Hausner<br />
ratio<br />
Contro 0.00 0.483±0.00 0.523±0.01 3.95±0.44 35.24±0.21 7.62±1.77 1.07±0.01 445<br />
Mean<br />
granule size<br />
µm<br />
PVP 1.00 0.416±0.20 0.450±0.00 4.74±0.52 36.74±0.56 7.41±1.28 1.08±0.01 485<br />
2.00 0.396±0.18 0.430±0.00 5.90±0.56 37.35±0.21 7.53±1.33 1.08±0.01 515<br />
3.00 0.416±0.19 0.430±0.00 6.63±0.57 36.62±0.21 3.10±1.33 1.03±0.01 585<br />
5.00 0.410±0.18 0.453±0.00 7.88±0.60 36.00±0.21 9.54±1.13 1.10±0.01 710<br />
ATR 1.00 0.427±0.00 0.433±0.00 5.20±0.41 48.86±0.56 1.55±1.34 1.01±0.01 755<br />
2.00 0.410±0.00 0.430±0.00 5.73±0.31 48.57±0.52 4.65±0.00 1.05±0.00 765<br />
3.00 0.400±0.01 0.440±0.01 7.22±0.29 49.63±0.14 9.09±0.20 1.09±0.00 770<br />
5.00 0.407±0.00 0.417±0.01 9.78±0.47 49.22±0.42 2.32±4.02 1.02±0.04 860<br />
The rele<strong>as</strong>e properties of the <strong>tablet</strong>s were <strong>as</strong>sessed us<strong>in</strong>g dis<strong>in</strong>tegration and dissolution times (t 50 and t 80<br />
i.e. time required for 50% and 80% of the drug to be rele<strong>as</strong>ed respectively). The dis<strong>in</strong>tegration time of <strong>tablet</strong>s is<br />
the rate limit<strong>in</strong>g step <strong>in</strong> dissolution and consequently absorption of the active <strong>in</strong>gredient. The British<br />
Pharmacopoeia [13], states that uncoated <strong>tablet</strong>s must dis<strong>in</strong>tegrate with<strong>in</strong> 15 m<strong>in</strong>utes. All the <strong>formulation</strong>s<br />
dis<strong>in</strong>tegrated <strong>in</strong> less than 15 m<strong>in</strong>utes. The result of the rele<strong>as</strong>e properties are presented <strong>in</strong> Table 2. The<br />
dis<strong>in</strong>tegration time w<strong>as</strong> observed to <strong>in</strong>cre<strong>as</strong>e with <strong>in</strong>cre<strong>as</strong>e <strong>in</strong> concentration of <strong>b<strong>in</strong>der</strong>.Formulations conta<strong>in</strong><strong>in</strong>g<br />
ATR at 5 % w/w had significantly lower (p0.05) <strong>in</strong> the dissolution time.<br />
Table 2: Tablet Properties<br />
B<strong>in</strong>der<br />
PVP<br />
ATR<br />
Concentration<br />
(% w/w)<br />
Friability<br />
(%)<br />
Crush<strong>in</strong>g<br />
strength<br />
(N)<br />
CSFR<br />
Dis<strong>in</strong>tegration<br />
time<br />
(M<strong>in</strong>)<br />
T 50<br />
(m<strong>in</strong>)<br />
T 80<br />
(m<strong>in</strong>)<br />
0.00 0.36±0.01 18.58±2.97 51.61 0.03±0.00 2.35 4.45<br />
1.00 0.53±0.03 27.46±3.80 51.81 0.07±0.01 2.35 4.50<br />
2.00 0.48±0.01 59.54±3.45 124.04 0.14±0.01 2.52 4.75<br />
3.00 0.44±0.01 96.68±3.88 219.72 0.38±0.06 2.75 5.25<br />
5.00 0.45±0.04 104.88±3.57 233.07 0.79±0.02 2.80 5.75<br />
1.00 0.69±0.02 22.56±2.86 32.70 0.07±0.02 2.25 5.25<br />
2.00 0.40±0.01 26.58±2.78 66.45 0.22±0.01 1.85 3.75<br />
3.00 0.30±0.02 39.56±3.00 131.87 0.31±0.00 2.35 5.35<br />
5.00 0.36±0.02 31.72±3.45 88.11 0.38±0.05 2.55 5.75<br />
31